B. Metzler Seel. Sohn & Co. Holding Ag Zai Lab LTD Transaction History

B. Metzler Seel. Sohn & Co. Holding Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$16.25 - $24.14 $55,282 - $82,124	-3,402 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$105.0 - $178.37 $63,000 - $107,022	600 Added 21.41%	3,402 $359,000
Q2 2021 Aug 30, 2021	BUY	$125.11 - $180.0 $25,022 - $36,000	200 Added 7.69%	2,802 $496,000
Q4 2020 Mar 08, 2021	BUY	$81.94 - $135.34 $213,207 - $352,154	2,602 New	2,602 $349,000

113

40.9M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Holding Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Holding Ag with notifications on news.